Export 2751 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
E. Trimble, Valmonte, C. M., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials in endometrial cancer.”, Oncology (Williston Park), vol. 14, no. 6, p. 850, 855, 859, 2000.
E. L. Trimble, Schoenfeldt, M., and Cornelison, T. L., “Clinical trials referral resource. Current clinical trails in endometrial cancer.”, Oncology (Williston Park), vol. 17, no. 2, pp. 238-40, 244, 249, 2003.
E. Trimble, Valmonte, C. M., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials in epithelial ovarian cancer.”, Oncology (Williston Park), vol. 14, no. 5, pp. 678, 683-4, 687-8 passim, 2000.
E. L. Trimble and Schoenfeldt, M., “Clinical trials referral resource. Current treatment trials for epithelial ovarian cancer.”, Oncology (Williston Park), vol. 19, no. 7, pp. 897-8, 900, 905-6 passim, 2005.
E. L. Trimble, Schoenfeldt, M., Streicher, H., Gius, D., and Cornelison, T. L., “Clinical Trials Referral Resource. Clinical trials in cervical cancer.”, Oncology (Williston Park), vol. 17, no. 1, pp. 84-9, 2003.
E. L. Trimble and Schoenfeldt, M., “Clinical trials referral source. Current randomized phase III trials in gynecologic cancer.”, Oncology (Williston Park), vol. 18, no. 13, pp. 1642, 1645-6, 2004.
M. H. Trivedi, Walker, R., Ling, W., Cruz, A. Dela, Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., A Rush, J., Nunes, E. V., and Shoptaw, S., “Bupropion and Naltrexone in Methamphetamine Use Disorder”, N Engl J Med, vol. 384, no. 2, pp. 140-153, 2021.
M. Trivedi, Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Warden, D., Ring, K., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, B., Oden, N., and Nunes, E., “Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial”, Trials, vol. 19, pp. 206-231, 2011.
M. H. Trivedi, Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Warden, D., Ring, K. M., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, B., Oden, N., and Nunes, E., “Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.”, Trials, vol. 12, p. 206, 2011.
K. E. Trocin, Weinstein, N. I., Oga, E. A., Mark, K. S., and Coleman-Cowger, V. H., “Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.”, J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
K. E. Trocin, Oga, E. A., Mulatya, C., Mark, K. S., and Coleman-Cowger, V. H., “Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy”, Matern Child Health J, vol. 26, no. 7, pp. 1488-1495, 2022.
K. Trocin, Oga, E. A., Mulatya, C., Mark, K. S., and Coleman-Cowger, V. H., “Qualitative Results from NIDA Grant”, Maternal Child Health, vol. 26, no. 7, 2022.
J. D. Troy, Atallah, E., Geyer, J. T., and Saber, W., “Myelodysplastic syndromes in the United States: an update for clinicians.”, Ann Med, vol. 46, no. 5, pp. 283-9, 2014.
J. D. Troy, Hill, H. R., Ewell, M. G., and Frey, S. E., “Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.”, Vaccine, vol. 33, no. 41, pp. 5425-5431, 2015.
J. D. Troy, Atallah, E., Geyer, J. T., and Saber, W., “Myelodysplastic Syndromes in the United States: An Update for Clinicians”, Ann Med, vol. 46, pp. 283-289, 2014.
E. Trujillo, Young, L., Chertow, G., Randall, S., Clemons, T., Jacobs, D., and Robinson, M., “Metabolic and monetary costs of avoidable parenteral nutritional use”, J Parenter Enteral Nutr, vol. 23, pp. 109-13, 1999.
E. B. Trujillo, Young, L. S., Chertow, G. M., Randall, S., Clemons, T., Jacobs, D. O., and Robinson, M. K., “Metabolic and monetary costs of avoidable parenteral nutrition use.”, JPEN J Parenter Enteral Nutr, vol. 23, no. 2, pp. 109-13, 1999.
E. L. Tsalik, Rouphael, N. G., Sadikot, R. T., Rodriguez-Barradas, M. C., McClain, M. T., Wilkins, D. M., Woods, C. W., Swamy, G. K., Walter, E. B., Sahly, H. M. El, Keitel, W. A., Mulligan, M. J., Tuyishimire, B., Serti, E., Hamasaki, T., Evans, S. R., Ghazaryan, V., Lee, M. S., and Lautenbach, E., “Efficacy and Safety of Azithromycin versus Placebo to Treat Lower Respiratory Tract Infections Associated with Low Procalcitonin: a Randomised, Placebo-controlled, Double-blind, Non-inferiority Trial”, Lancet Infect Dis, vol. 23, no. 4, pp. 484-495, 2023.
E. T. Tsilou, Thompson, D., Lindblad, A. S., Reed, G. F., Rubin, B., Gahl, W., Thoene, J., Del Monte, M. A., Schneider, J. A., Granet, D. B., and Kaiser-Kupfer, M. I., “A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis”, Brit J Ophthalmol, vol. 87, pp. 28-31, 2003.
E. T. Tsilou, Thompson, D., Lindblad, A. S., Reed, G. F., Rubin, B., Gahl, W., Thoene, J., Del Monte, M., Schneider, J. A., Granet, D. B., and Kaiser-Kupfer, M. I., “A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.”, Br J Ophthalmol, vol. 87, no. 1, pp. 28-31, 2003.
L. M. Turcotte, DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., Slungaard, A., Blazar, B. R., Weisdorf, D. J., Panoskaltsis-Mortari, A., and Holtan, S. G., “Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.”, Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
V
F. van Asten, Chiu, C. - Y., Agrón, E., Clemons, T. E., Ratnapriya, R., Swaroop, A., Klein, M. L., Fan, R., and Chew, E. Y., “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
F. van Asten, Simmons, M., Singhal, A., Keenan, T. D., Ratnapriya, R., Agrón, E., Clemons, T. E., Swaroop, A., Lu, Z., and Chew, E. Y., “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
L. Van Damme, Niruthisard, S., Atisook, R., Boer, K., Dally, L., Laga, M., Lange, J. M., Karam, M., and Perriens, J. H., “Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.”, AIDS, vol. 12, no. 4, pp. 433-7, 1998.
L. Van Damme, Niruthisard, S., Atisook, R., Boer, K., Dally, L., Laga, M., Lange, J. M., Karam, M., and Perriens, J. H., “Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection”, AIDS, vol. 12, pp. 433-7, 1998.